Ocrelizumab treatment in multiple sclerosis: A Danish population‐based cohort study-论文-万方医学网

Ocrelizumab treatment in multiple sclerosis: A Danish population‐based cohort study

导出原文传递

翻译打印收藏纠错

作者： Luigi Pontieri ^[1] ; Morten Blinkenberg ^[2] ; Stephan Bramow ^[3] ; Viktoria Papp ^[4] ; Peter V. Rasmussen ^[5] ; Matthias Kant ^[6] ; Jakob Sch?fer ^[7] ; Henrik K. Mathiesen ^[8] ; Michael B. Jensen ^[9] ; Georgi Sirakov ^[10] ; Jonas M. Berg ; Tine I. Kopp ; Hanna Joensen ; Finn Sellebjerg ; Melinda Magyari

作者单位： The Danish Multiple Sclerosis Registry,Copenhagen University Hospital—Rigshospitalet ^[1] Danish Multiple Sclerosis Center,Copenhagen University Hospital—Rigshospitalet ^[2] Odense University Hospital ^[3] Aarhus University Hospital ^[4] Hospital of Southern Jutland ^[5] Department of Neurology,University Hospital Aalborg ^[6] Department of Neurology,Copenhagen University Hospital Herlev and Gentofte ^[7] Department of Neurology,University Hospital of Northern Sealand ^[8] Regional Hospital West Jutland ^[9] Viborg Regional Hospital ^[10]

关键词 anti‐CD20 monoclonal antibody multiple sclerosis ocrelizumab real‐world studies registry

发布时间 2022-04-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除